Sage Therapeutics, Inc. - COM (SAGE)

Q3 2021 13F Holders as of 9/30/2021

Type / Class
Equity / COM
Number of holders
218
Total Shares
49M
Shares change
-1.49M
Total reported value, excl. options
$2.17B
Value change
-$115M
Put/Call ratio
2.2
Number of buys
115
Number of sells
-120
Price
$44.31
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.